Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FXA90
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,617
Award facts
- Contract value 100% obligated
- $31,617.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,617.17 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by August 27, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company maintains an established track record of competitively awarded contracts with the Defense Logistics Agency and serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard. Dupixent (dupilumab) is a biologic immunosuppressant medication commonly used in military healthcare for the treatment of moderate-to-severe atopic dermatitis and other inflammatory conditions, making this delivery order consistent with the company's portfolio of specialty pharmaceutical products supporting military medical readiness.
Quick answers
Who was awarded contract SPE2DB25FXA90?
SPE2DB25FXA90 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FXA90 worth?
The government has obligated $31,617 on SPE2DB25FXA90.
Is contract SPE2DB25FXA90 an order under another contract?
Yes. SPE2DB25FXA90 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXA90 competed?
The extent of competition for SPE2DB25FXA90 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award